OAG
CELG

Orbis Allan Gray’s Celgene Corp CELG Stock Holding History

Orbis Allan Gray’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,187,955
Closed -$714M – 67
2019
Q3 		$714M Sell
7,187,955
-2,256,521
-24% -$214M 5.27% 5
2019
Q2 		$873M Sell
9,444,476
-4,452,234
-32% -$423M 6.28% 5
2019
Q1 		$1.31B Sell
13,896,710
-650,980
-4% -$56.9M 8.89% 3
2018
Q4 		$932M Buy
14,547,690
+4,165,188
+40% +$307M 6.71% 4
2018
Q3 		$929M Buy
10,382,502
+126,708
+1% +$11.2M 5.34% 4
2018
Q2 		$815M Buy
10,255,794
+3,855,062
+60% +$320M 4.52% 5
2018
Q1 		$571M Buy
6,400,732
+6,154,826
+2,503% +$591M 3.26% 10
2017
Q4 		$25.7M Buy
245,906
+216,043
+723% +$24.4M 0.15% 44
2017
Q3 		$4.36M Hold
29,863
– – 0.03% 61
2017
Q2 		$3.88M Sell
29,863
-944,811
-97% -$116M 0.02% 59
2017
Q1 		$121M Sell
974,674
-1,525,243
-61% -$183M 0.83% 31
2016
Q4 		$289M Buy
2,499,917
+435,767
+21% +$48.5M 2.08% 19
2016
Q3 		$216M Buy
2,064,150
+227,594
+12% +$24.6M 1.51% 22
2016
Q2 		$181M Buy
1,836,556
+641,323
+54% +$66.3M 1.38% 22
2016
Q1 		$120M Buy
+1,195,233
New +$123M 0.97% 26

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Orbis Allan Gray's CELG Position: Q4 2019 in Review

Orbis Allan Gray sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,187,955 shares — an estimated $714M sold.

Orbis Allan Gray first reported a position in CELG in Q1 2016 and held it in 15 quarters. The position peaked at $1.31B in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Orbis Allan Gray reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Orbis Allan Gray sold 7,187,955 Celgene Corp shares in Q4 2019, an estimated $714M.
  • Orbis Allan Gray first reported a position in Celgene Corp in Q1 2016 and held it in 15 quarters.
  • Orbis Allan Gray's Celgene Corp position peaked at $1.31B in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Orbis Allan Gray's 13F filing for Q4 2019, filed 14 Feb 2020.